Summary
This drug is looking for approval in the Danish market for CLL, BUT... Rituxan (Vitamin R) is used extensively off label with and without other agents and is considered a vital part of therapy for CLL.
Analysis
Is this better than Rituxan? (Genentech/biogen)
Were patients in trials failures on Rituxan?
It may well be approved but it will need to show better efficacy than Vitamin "R", lower price, or less side effects. A tough hurdle to jump!
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
